1H Magnetic resonance spectroscopy in dementia
KANTARCI
Br. J. Radiol. 2007;80:S146-S152.
ABSTRACT
| FULL TEXT
Methamphetamine Users in Sustained Abstinence: A Proton Magnetic Resonance Spectroscopy Study
Nordahl et al.
Arch Gen Psychiatry 2005;62:444-452.
ABSTRACT
| FULL TEXT
1H MR spectroscopy in common dementias
Kantarci et al.
Neurology 2004;63:1393-1398.
ABSTRACT
| FULL TEXT
Measurement of Gelatinase B (MMP-9) in the Cerebrospinal Fluid of Patients With Vascular Dementia and Alzheimer Disease
Adair et al.
Stroke 2004;35:e159-e162.
ABSTRACT
| FULL TEXT
Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD
Schuff et al.
Neurology 2003;61:358-364.
ABSTRACT
| FULL TEXT
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias
Hsu et al.
J Geriatr Psychiatry Neurol 2001;14:145-166.
ABSTRACT
Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD
Jessen et al.
Neurology 2000;55:684-688.
ABSTRACT
| FULL TEXT
Subcortical Ischemic Vascular Dementia: Assessment with Quantitative MR Imaging and 1H MR Spectroscopy
Capizzano et al.
Am. J. Neuroradiol. 2000;21:621-630.
ABSTRACT
| FULL TEXT
Brain Biochemistry Using Magnetic Resonance Spectroscopy: Relevance to Psychiatric Illness in the Elderly
Moore et al.
J Geriatr Psychiatry Neurol 1999;12:107-117.
ABSTRACT
Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study
Hu et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:20-26.
ABSTRACT
| FULL TEXT
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging
Barber et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:66-72.
ABSTRACT
| FULL TEXT
In Vivo Brain Concentrations of N-Acetyl Compounds, Creatine, and Choline in Alzheimer Disease
Pfefferbaum et al.
Arch Gen Psychiatry 1999;56:185-192.
ABSTRACT
| FULL TEXT